These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

817 related items for PubMed ID: 16944258

  • 1. Relationship between clinical efficacy of treatment of pulmonary Mycobacterium avium complex disease and drug-sensitivity testing of Mycobacterium avium complex isolates.
    Kobashi Y, Yoshida K, Miyashita N, Niki Y, Oka M.
    J Infect Chemother; 2006 Aug; 12(4):195-202. PubMed ID: 16944258
    [Abstract] [Full Text] [Related]

  • 2. Relationship between clinical efficacy for pulmonary MAC and drug-sensitivity test for isolated MAC in a recent 6-year period.
    Kobashi Y, Abe M, Mouri K, Obase Y, Kato S, Oka M.
    J Infect Chemother; 2012 Aug; 18(4):436-43. PubMed ID: 22205543
    [Abstract] [Full Text] [Related]

  • 3. The clinical efficacy and safety of a fluoroquinolone-containing regimen for pulmonary MAC disease.
    Fujita M, Kajiki A, Tao Y, Miyazaki M, Ouchi H, Harada E, Ikegame S, Matsumoto T, Uchino J, Watanabe K, Nakanishi Y.
    J Infect Chemother; 2012 Apr; 18(2):146-51. PubMed ID: 21927844
    [Abstract] [Full Text] [Related]

  • 4. Analysis of drug treatment outcome in clarithromycin-resistant Mycobacterium avium complex lung disease.
    Kadota T, Matsui H, Hirose T, Suzuki J, Saito M, Akaba T, Kobayashi K, Akashi S, Kawashima M, Tamura A, Nagai H, Akagawa S, Kobayashi N, Ohta K.
    BMC Infect Dis; 2016 Jan 27; 16():31. PubMed ID: 26818764
    [Abstract] [Full Text] [Related]

  • 5. [Effect of combined chemotherapy following the guidelines on treatment for Mycobacterium avium complex pulmonary disease].
    Kobashi Y, Okimoto N, Matsushima T, Shigetou E, Kuraoka T, Takeyama H, Eda R, Yano S, Kobayashi K, Ohnishi T, Mori K, Ueda Y, Moritaka T, Nishimura K, Abe T.
    Kekkaku; 2002 Jun 27; 77(6):435-41. PubMed ID: 12136597
    [Abstract] [Full Text] [Related]

  • 6. Difference in drug susceptibility distribution and clinical characteristics between Mycobacterium avium and Mycobacterium intracellulare lung diseases in Shanghai, China.
    Wang W, Yang J, Wu X, Wan B, Wang H, Yu F, Guo Y.
    J Med Microbiol; 2021 May 27; 70(5):. PubMed ID: 33999797
    [Abstract] [Full Text] [Related]

  • 7. A double-blind randomized study of aminoglycoside infusion with combined therapy for pulmonary Mycobacterium avium complex disease.
    Kobashi Y, Matsushima T, Oka M.
    Respir Med; 2007 Jan 27; 101(1):130-8. PubMed ID: 16750618
    [Abstract] [Full Text] [Related]

  • 8. [Clinical features and treatment history of clarithromycin resistance in M. avium-intracellulare complex pulmonary disease patients].
    Kuwabara K, Tsuchiya T.
    Nihon Kokyuki Gakkai Zasshi; 2007 Aug 27; 45(8):587-92. PubMed ID: 17763685
    [Abstract] [Full Text] [Related]

  • 9. The effect of combined therapy according to the guidelines for the treatment of Mycobacterium avium complex pulmonary disease.
    Kobashi Y, Matsushima T.
    Intern Med; 2003 Aug 27; 42(8):670-5. PubMed ID: 12924489
    [Abstract] [Full Text] [Related]

  • 10. Effective treatment for clarithromycin-resistant Mycobacterium avium complex lung disease.
    Adachi Y, Tsuyuguchi K, Kobayashi T, Kurahara Y, Yoshida S, Kagawa T, Hayashi S, Suzuki K.
    J Infect Chemother; 2020 Jul 27; 26(7):676-680. PubMed ID: 32171660
    [Abstract] [Full Text] [Related]

  • 11. Therapeutic effects of various initial combinations of chemotherapy including clarithromycin against Mycobacterium avium complex pulmonary disease.
    Hasegawa N, Nishimura T, Ohtani S, Takeshita K, Fukunaga K, Tasaka S, Urano T, Ishii K, Miyairi M, Ishizaka A.
    Chest; 2009 Dec 27; 136(6):1569-1575. PubMed ID: 19542259
    [Abstract] [Full Text] [Related]

  • 12. [The clinical study on efficacy of clarithromycin, levofloxacin, and streptomycin for pulmonary Mycobacterium avium-intracellulare complex infection].
    Taga S, Ogawa K, Nakagawa T, Tano M.
    Kekkaku; 2005 Jan 27; 80(1):1-7. PubMed ID: 15839056
    [Abstract] [Full Text] [Related]

  • 13. First line treatment selection modifies disease course and long-term clinical outcomes in Mycobacterium avium complex pulmonary disease.
    Fukushima K, Kitada S, Komukai S, Kuge T, Matsuki T, Kagawa H, Tsujino K, Miki M, Miki K, Kida H.
    Sci Rep; 2021 Jan 13; 11(1):1178. PubMed ID: 33441977
    [Abstract] [Full Text] [Related]

  • 14. Antibacterial activity and clinical efficacy of sparfloxacin in Mycobacterium avium-intracellulare complex infection.
    Horiguchi T, Kondo R, Miyazaki J, Shiga M, Sugiyama M, Handa M, Munekata E.
    J Int Med Res; 2004 Jan 13; 32(5):530-9. PubMed ID: 15458286
    [Abstract] [Full Text] [Related]

  • 15. [In vitro susceptibilities of Mycobacterium avium and Mycobacterium intracellulare to new macrolides, new quinolones, and antituberculous drugs on Dubos agar medium].
    Ogawa K, Miwa T, Sasamoto M, Sasaki T, Tsuda M, Honda K, Furui H, Torii K, Takagi K.
    Kekkaku; 1992 Nov 13; 67(11):735-8. PubMed ID: 1487866
    [Abstract] [Full Text] [Related]

  • 16. Differences in drug susceptibility pattern between Mycobacterium avium and Mycobacterium intracellulare isolated in respiratory specimens.
    Cho EH, Huh HJ, Song DJ, Moon SM, Lee SH, Shin SY, Kim CK, Ki CS, Koh WJ, Lee NY.
    J Infect Chemother; 2018 Apr 13; 24(4):315-318. PubMed ID: 29223615
    [Abstract] [Full Text] [Related]

  • 17. Therapeutic effect of KRM-1648 with various antimicrobials against Mycobacterium avium complex infection in mice.
    Saito H, Tomioka H, Sato K, Kawahara S, Hidaka T, Dekio S.
    Tuber Lung Dis; 1995 Feb 13; 76(1):51-8. PubMed ID: 7718848
    [Abstract] [Full Text] [Related]

  • 18. [Clinical efficacy of kanamycin for Mycobacterium avium complex disease].
    Suzuki A, Nishimura T, Ohtawa S, Mikami J, Kurashima A, Saito M, Mita M.
    Yakugaku Zasshi; 2008 Mar 13; 128(3):451-60. PubMed ID: 18311066
    [Abstract] [Full Text] [Related]

  • 19. Comparison of clarithromycin-sensitive and clarithromycin-resistant Mycobacterium avium strains isolated from AIDS patients during therapy regimens including clarithromycin.
    Matsiota-Bernard P, Zinzendorf N, Onody C, Guenounou M.
    J Infect; 2000 Jan 13; 40(1):49-54. PubMed ID: 10762111
    [Abstract] [Full Text] [Related]

  • 20. [In vitro antimycobacterial activity of clarithromycin and its therapeutic efficacy against Mycobacterium intracellulare infection induced in mice].
    Tomioka H, Sato K, Saito H.
    Kekkaku; 1993 Apr 13; 68(4):293-9. PubMed ID: 8497119
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 41.